Side-by-side comparison of AI visibility scores, market position, and capabilities
Alphabet (NASDAQ: GOOGL) free web analytics on 50%+ of all websites; GA4 event-based model with BigQuery integration and ML-powered insights competing with Adobe Analytics and Amplitude for digital measurement.
Google Analytics is Alphabet's (NASDAQ: GOOGL) free web and app analytics platform — the world's most widely deployed digital analytics tool, installed on 50%+ of all websites globally — providing marketers, analysts, and developers with traffic measurement, user behavior analysis, conversion tracking, and audience insights for websites and mobile applications. Google Analytics 4 (GA4), launched in 2020 and replacing Universal Analytics in 2023, represents a fundamental architectural shift from session-based measurement to event-based data modeling, enabling cross-device and cross-platform tracking as the modern web's cookie deprecation and mobile app proliferation require.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.